- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beijing Luzhu Biotechnology Co Ltd (2480)
Beijing Luzhu Biotechnology Co Ltd stock price live, this page displays HK 2480 stock exchange data. View the 2480 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beijing Luzhu Biotechnology Co Ltd real time stock price chart below.
What Is the Beijing Luzhu Biotechnology Co Ltd Stock Price Today?
The Beijing Luzhu Biotechnology Co Ltd stock price today is 24.64.
What Is the Stock Symbol for Beijing Luzhu Biotechnology Co Ltd?
The stock symbol for Beijing Luzhu Biotechnology Co Ltd is ""2480.""
What Stock Exchange Does Beijing Luzhu Biotechnology Co Ltd Trade On?
Beijing Luzhu Biotechnology Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Beijing Luzhu Biotechnology Co Ltd a Good Stock to Buy?
Determining whether Beijing Luzhu Biotechnology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2480 quote. (ISIN: CNE100005YD8)
What Is the Beijing Luzhu Biotechnology Co Ltd Stock Price Today?
The Beijing Luzhu Biotechnology Co Ltd stock price today is 24.64.
What Is the Stock Symbol for Beijing Luzhu Biotechnology Co Ltd?
The stock symbol for Beijing Luzhu Biotechnology Co Ltd is ""2480.""
What Stock Exchange Does Beijing Luzhu Biotechnology Co Ltd Trade On?
Beijing Luzhu Biotechnology Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Beijing Luzhu Biotechnology Co Ltd a Good Stock to Buy?
Determining whether Beijing Luzhu Biotechnology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2480 quote. (ISIN: CNE100005YD8)
Hong Kong
Currency in HKD
24.64
+0.10(+0.41%)
Closed·
Fair Value
An estimate of a Beijing Luzhu Biotechnology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.62
24.80
52 wk Range
20.00
28.00
2480 Scorecard
Full Analysis
Management has been aggressively buying back shares
2480 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Beijing Luzhu Biotechnology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.6224.80
52 wk Range
20.0028.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2480 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Beijing Luzhu Biotechnology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
31.73
Upside
+28.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Beijing Luzhu Biotechnology Co Ltd Company Profile
Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine, which completed Phase III clinical trial; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of various autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis, that completed Phase I clinical trial; and K193, a bispecific antibody injection to treat B cell leukemia and lymphoma, which is in Phase I clinical trial. The company’s pre-clinical-stage product candidates comprise Recombinant Varicella vaccine for the prevention of varicella in children; Recombinant Syncytial Virus (RSV) vaccine for the indication of RSV-induced lower respiratory tract disease; Recombinant HSV-1 vaccine that targets oral herpes or cold sores; Recombinant HSV-2 vaccine targets genital herpes; K333, a bispecific antibody injection product for the treatment of myeloid leukemia; and K1932 bispecific antibody to treat b cell lymphoma. In addition, it offers immunoreagents, such as Group A meningococcal polysaccharide IgG, Group C meningococcal polysaccharide IgG, Group Y meningococcal polysaccharide IgG, Group W135 meningococcal polysaccharide IgG, and Haemophilus influenzae Type B polysaccharide IgG antibody detection kits. The company was formerly known as Beijing Luzhu Biotech. The company was incorporated in 2001 and is headquartered in Beijing, China.
Compare 2480 to Peers and Sector
Metrics to compare | 2480 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2480PeersSector | |
|---|---|---|---|---|
P/E Ratio | −33.0x | −18.6x | −0.5x | |
PEG Ratio | −0.65 | 0.14 | 0.00 | |
Price/Book | 6.1x | 5.8x | 2.6x | |
Price / LTM Sales | - | 21.1x | 3.2x | |
Upside (Analyst Target) | 28.8% | −5.1% | 38.8% | |
Fair Value Upside | Unlock | −11.9% | 5.4% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.73
(+28.78% Upside)
Earnings
Latest Release
Aug 26, 2025
EPS / Forecast
-0.39 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Beijing Luzhu Biotechnology Trade On?
Beijing Luzhu Biotechnology is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Beijing Luzhu Biotechnology?
The stock symbol for Beijing Luzhu Biotechnology is "2480."
What Is the Beijing Luzhu Biotechnology Market Cap?
As of today, Beijing Luzhu Biotechnology market cap is 4.90B.
What Is Beijing Luzhu Biotechnology's Earnings Per Share (TTM)?
The Beijing Luzhu Biotechnology EPS (TTM) is -0.68.
From a Technical Analysis Perspective, Is 2480 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Beijing Luzhu Biotechnology Stock Split?
Beijing Luzhu Biotechnology has split 0 times.
How Many Employees Does Beijing Luzhu Biotechnology Have?
Beijing Luzhu Biotechnology has 197 employees.
What is the current trading status of Beijing Luzhu Biotechnology (2480)?
As of 31 Aug 2025, Beijing Luzhu Biotechnology (2480) is trading at a price of 24.64, with a previous close of 24.54. The stock has fluctuated within a day range of 24.62 to 24.80, while its 52-week range spans from 20.00 to 28.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.